Gene · 34
Papers1,869
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 1,869
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic approach in adult-onset neurometabolic diseases. | J Neurol Neurosurg Psychiatry | 2022 | 35140137 | PubTator, text mining | PubMed |
| Mitochondrial hepatopathy: Anticipated difficulties in management of fatty acid oxidation defects and urea cycle defects. | World J Hepatol | 2022 | 35126847 | PubTator, text mining | PubMed |
| Trans-ethnic genome-wide association study of blood metabolites in the Chronic Renal Insufficiency Cohort (CRIC) study. | Kidney Int | 2022 | 35120996 | PubTator, text mining | PubMed |
| Identification and validation of serum autoantibodies in children with B-cell acute lymphoblastic leukemia by serological proteome analysis. | Proteome Sci | 2022 | 35109855 | PubTator, text mining | PubMed |
| Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids. | iScience | 2022 | 35106453 | PubTator, text mining | PubMed |
| Depletion of mitochondrial methionine adenosyltransferase α1 triggers mitochondrial dysfunction in alcohol-associated liver disease. | Nat Commun | 2022 | 35091576 | PubTator, text mining | PubMed |
| Mendelian etiologies identified with whole exome sequencing in cerebral palsy. | Ann Clin Transl Neurol | 2022 | 35076175 | PubTator, text mining | PubMed |
| Medium branched chain fatty acids improve the profile of tricarboxylic acid cycle intermediates in mitochondrial fatty acid β-oxidation deficient cells: A comparative study. | J Inherit Metab Dis | 2022 | 35076099 | PubTator, text mining | PubMed |
| Sodium butyrate potentiates insulin secretion from rat islets at the expense of compromised expression of β cell identity genes. | Cell Death Dis | 2022 | 35046383 | PubTator, text mining | PubMed |
| Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progression. | J Exp Clin Cancer Res | 2022 | 35045880 | PubTator, text mining | PubMed |
| MCAD deficiency caused by compound heterozygous pathogenic variants in ACADM. | Hum Genome Var | 2022 | 35034956 | PubTator, text mining | PubMed |
| Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids. | Hepatology | 2022 | 35030285 | PubTator, text mining | PubMed |
| Identification of recurrent pathogenic alleles using exome sequencing data: Proof-of-concept study of Russian subjects. | Eur J Med Genet | 2022 | 35026467 | PubTator, text mining | PubMed |
| Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells. | Nat Commun | 2022 | 35013148 | PubTator, text mining | PubMed |
| Predicting the targets of IRF8 and NFATc1 during osteoclast differentiation using the machine learning method framework cTAP. | BMC Genomics | 2022 | 34991467 | PubTator, text mining | PubMed |
| Developmental toxicity of Nafion byproduct 2 (NBP2) in the Sprague-Dawley rat with comparisons to hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) and perfluorooctane sulfonate (PFOS). | Environ Int | 2022 | 34952357 | PubTator, text mining | PubMed |
| Vulnerable exons, like ACADM exon 5, are highly dependent on maintaining a correct balance between splicing enhancers and silencers. | Hum Mutat | 2022 | 34923709 | PubTator, text mining | PubMed |
| Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker. | Alcohol | 2022 | 34923085 | PubTator, text mining | PubMed |
| A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease. | Kidney Int | 2022 | 34843755 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/34/papers?page=23